Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-29

Clinical Trial Update: Reversing the Effects of 0.5% Bupivacaine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update studying reversal of effects of 0.5% bupivacaine in local anesthesia conditions; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)

Snippet

Sponsor: Dalhousie University | Conditions: Anesthesia, Local | Phase 4 | Status: COMPLETED